实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (4): 589-592.doi: 10.3969/j.issn.1672-5069.2018.04.026

• 肝硬化 • 上一篇    下一篇

血清胱抑素C对肝硬化患者肾损伤的诊断效能研究

王容, 周焱, 赵川, 李毅, 杨凤   

  1. 629000四川省遂宁市中心医院感染病科(王容,赵川,李毅,杨凤); 四川大学华西附属第一医院老年医学中心/干部医疗科(周焱)
  • 收稿日期:2017-07-01 出版日期:2018-07-10 发布日期:2018-07-12
  • 作者简介:王容,女,48岁,大学本科,副主任医师。主要从事各型肝炎和结核等传染病的防治研究。E-mail:13518367112@163.com

Diagnostic efficacy of serum cystatin C on acute kidney injury in patients with liver cirrhosis

Wang Rong, Zhou Yan, Zhao Chuan, et al   

  1. Department of Infectious Diseases,Central Hospital,Suining 629000,Sichuan Province
  • Received:2017-07-01 Online:2018-07-10 Published:2018-07-12

摘要: 目的 探讨应用血清胱抑素C水平诊断肝硬化患者并发急性肾损伤(AKI)的临床价值。方法 2015年1月~2017年2月我院接受治疗的114例肝硬化患者,按照血清肌酐水平在48 h内≥25.5 μmol/L诊断,结果并发AKI患者62例【其中急性肾小管坏死(ATN)8例,肝肾综合症(HRS)16例和前性氮质血症(PRA)38例】,非AKI患者52例。采用增强免疫比浊法检测血清胱抑素C。结果 AKI组合并冠心病19例,糖尿病17例,高血压16例,显著高于非AKI组的12例、10例和11例(P<0.05);AKI组血清胱抑素C水平为(2.4±0.2) mg/L,显著高于非AKI组的(0.9±0.1) mg/L,白蛋白为(28.3±4.8) g/L,显著低于非AKI组的(34.1±7.3) g/L(P<0.05);尿素氮为(15.3±5.4) mmol/L,血小板计数为(73.1±11.3)×109/L,总胆红素为(43.8±9.5) μmol/L,血肌酐为(127.6±23.5) μmol/L,与非AKI组的(6.4±3.3) mmol/L、(90.6±12.7)×109/L、(23.6±6.4) μmol/L和(73.4±15.2) μmol/L比,差异显著(P<0.05);ATN组血胱抑素C水平为(3.6±1.6) mg/L,血小板计数为(102.6±21.7)×109/L,总胆红素为(73.2±16.8) μmol/L,血肌酐为(346.8±30.7) μmol/L,均显著高于HRS组或PRA组(P<0.05);血清胱抑素C诊断AKI的准确度为92.1%,特异度为95.7%,显著高于血肌酐或尿素氮。结论 血胱抑素C水平检测可帮助早期诊断肝硬化患者并发AKI,或有利于临床早期处理。

关键词: 肝硬化, 急性肾损伤, 血清胱抑素C, 诊断

Abstract: Objective To explorethe diagnostic efficacy of serum cystatin C on acute kidney injury (AKI) in patients with liver cirrhosis. Methods 114 patients with liver cirrhosis were recruited between January 2015 and February 2017 in our hospital,and 62 of them had AKI and 52 without. The AKI included acute tubular necrosis (ATN) in 8,hepatorenal syndrome (HRS) in 16 and prerenal azotemia (PRA) in 38. Serum albumin,total bilirubin,creatinine,urea nitrogen and cystatin C were detected,and the sensitivity,specificity and accuracy were calculated. Results 19 had coronary heart disease,17 had diabetes,and 16 had hypertension in patients with AKI,significantly higher than 12,10 and 11 in patients without(P<0.05);serum cystatin C in patients with AKI was (2.4±0.2) mg/L,much higher than (0.9±0.1) mg/L,and serum albumin was(28.3±4.8) g/L,much lower than (34.1±7.3) g/L(P<0.05) in patients without;urea nitrogen was(15.3±5.4) mmol/L,platelet counts was (73.1±11.3)×109/L,total bilirubin was(43.8±9.5) μmol/L,creatinine was(127.6±23.5) μmol/L,significantly different as compared to (6.4±3.3) mmol/L,(90.6±12.7)×109/L,(23.6±6.4) μmol/L,(73.4±15.2) μmol/L in patients without AKI (P<0.05);in the ATN group,serum cystatin C level was (3.6±1.6) mg/L,platelet counts was (102.6±21.7)× 109/L, total bilirubin was (73.2±16.8)μmol/L,serum creatinine was(346.8±30.7) μmol/L,much higher than those in HRS group and in PRA group(P<0.05);the accuracy was 92.1% and the specificity was 95.7% when serum cystatin C was used to diagnose the patients with AKI,significantly higher than those by serum creatinine or urea nitrogen(P<0.05). Conclusion The application of serum cystatin C level in the diagnosis of liver cirrhosis patients with AKI is helpful in clinical practice,which needs further investigation.

Key words: Liver cirrhosis, Acute kidney injury, Serum Cystatin C, Diagnosis